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Abstract
Background: Globally, chronic B viral hepatitis (HBV) is a major health problem. Obesity is a common problem among pa-
tients with HBV. Several studies have reported that obesity is an important risk factor that alters immune system response in 
individuals with no underlying cause of  liver disease. However, there is a strong association between BMI and the human im-
mune system among HBV patients. 
Objective: This study was to examine the correlation between body mass index, serum alanine aminotransferase activity (ALT) 
and immunologic response in obese hepatitis B patients. 
Material and methods: One hundred fifty male patients with chronic hepatitis B virus, their age ranged from 30 to 45 (38.64 ± 
7.12) years and their BMI ranged from 30-35 kg/m2. All Subjects were included in two groups: The first group received weight 
reduction program in the form of  treadmill aerobic exercises in addition to diet control whereas the second group received no 
therapeutic intervention. Parameters of  serum alanine aminotransferase (ALT), CD3, CD4 and CD8 were quantified; Leukocyte, 
differential counts and body mass index (BMI) were measured before and after 3 months at the end of  the study. 
Results: There was a 24.7%, 36.8%, 30.8%, 40.7%, 28.6%, 25.9%, 33.3% and 14.3 % reduction in mean values of  alanine ami-
notransferase (ALT), white blood cells, total neutrophil count, monocytes, CD3, CD4 ,CD8 and BMI respectively in group (A) at 
the end of  the study. In addition, there were significant differences between mean levels of  the investigated parameters in groups. 
Conclusion: Based on our findings, weight loss modulates serum alanine aminotransferase and immune system parameters of  
patients with hepatitis B virus infection.
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Introduction
Hepatitis B virus (HBV) causes inflammation of  the liver 
in humans and is a major public health problem world-
wide. About a quarter of  the world population (>2 bil
lion) has been infected with HBV, including 350 million 
with chronic or lifelong HBV infection1. HBV is 50–100 
times more infectious than human immuno-deficiency vi-
rus (HIV)2,3.
 
HBV carriers are at risk of  developing life threatening 
cirrhosis and later on hepatic carcinoma. The long-term 
aim in the treatment of  these patients is to prevent the 
development of  cirrhosis and hepatocellular carcinoma4. 
The immune responses to HBV antigens are responsible 
both for viral clearance during acute infection and for 
disease pathogenesis. Immune responses involved in viral 
clearance comprise both humoral and cellular immunity 
where CD4+ helper T cells contribute to generation of  
antibodies against viral envelope antigens that clear circu-
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lating viral particles and CD8+ cytotoxic T lymphocytes 
eliminate infected cells5.
 
Obesity is a major health problem since excessive body 
weight constitutes a risk factor in a number of  chronic 
diseases. The prevalence of  obesity is increasing world-
wide and as per the latest WHO estimates, approximately 
500 million adults and nearly forty three million children 
under the age of  5 years appear to be obese, showing a 
BMI ≥ 30 kg/m2 6. Immune-competence is dependent on 
nutritional status and can be easily dysregulated in states 
of  imbalanced nutrition such as under nutrition (mal-
nutrition) or over nutrition (obesity). However, immune 
suppression in undernourished state is well known7.
 
Many authors reported dysregulation and alteration in 
number of  immune cells in obese subjects. Obese sub-
jects showed either increased or decreased total lym-
phocytes in peripheral blood populations8-11 and had de-
creased CD8+ T cell population along with increased or 
decreased CD4+T cells10,11. Therefore, the purpose of  
this study was to examine the correlation between body 
mass index, serum alanine aminotransferase (ALT) activ-
ity and immunologic response in obese HBV patients.
As there is limitation in studies reporting the benefits of  
lifestyle modification on immune system response among 
patients with HBV, this study aimed to examine effects 
of  weight reduction program on selected immune param-
eters among HBV patients.
Patients and methods
Subjects
One hundred fifty male patients with chronic hepatitis B; 
their age ranged from 30 to 45 (38.64 ± 7.12) years and 
their BMI ranged from 30-35 kg/m2, were studied on re-
ferral to Gastroenterology and Hepatology Department, 
King Abdulaziz University Teaching Hospital, Saudi Ara-
bia. Only patients diagnosed with chronic HBV mono-
infection had undergone Real-Time polymerase chain re-
action. The inclusion criteria was as follows: Positive test 
for serum hepatitis B surface antigen (HBsAg), negative 
for HBeAg for at least six months, elevated serum ALT 
level recorded at least 2 distinct instances at an interval of  
one month, and HBV DNA level > 2000 IU/mL (Co-
basAmplicor HBV monitor, which has a detection limit 
of  12 IU/mL). Anti-viral treatment for all enrolled pa-
tients followed the American Association for the Study 
of  Liver Disease (AASLD) treatment guidelines12.
The exclusion criteria was as follows: patients with 
hepatitis C virus, alcoholic liver disease and radiologic 
evidence of  hepatitis C cirrhosis (HCC). The Scientific 
Research Ethical Committee, Faculty of  Applied Medi-
cal Sciences at King Abdulaziz University, approved this 
study. All participants were free to withdraw from the 
study at any time. Patients were randomly divided in to 
two equal groups: Group A included 75 patients who re-
ceived weight reduction program in the form of  tread-
mill aerobic exercises in addition to diet control, whereas 
group B received no therapeutic intervention.
Measurements
All measurements indicated below were taken before the 
beginning of  the study and after 3 months at the end of  
the study.
 
A. Flow cytometry analysis: The human leukocyte 
differentiation antigens CD3, CD4 and CD8 (Beckman 
Coulter, Marseille, France) five microliters of  appropri-
ate monoclonal antibody was added to 50 µL of  a whole 
blood sample and incubated for 15 minutes at room tem-
perature. Thereafter, the erythrocytes were lysed with 125 
µL of  a lysing solution, OptiLyse C, for 10 minutes. The 
reaction stopped by the addition of  250 µL phosphate-
buffered saline. The samples analyzed by flow cytome-
try using Cytomics FC500 and CXP software (Beckman 
Coulter). The leukocyte subsets were defined by forward- 
and side-scatter pattern. A fluorescence background and 
antibody-nonspecific staining determined the negative 
control value.
 
B. Analysis of  peripheral blood cells: The analysis of  
peripheral blood cells (e.g., total and differential count) 
was performed on a Beckman Coulter AcT 5diff  hema-
tology analyzer. The values were expressed in percentages 
and absolute numbers.
 
C. Serum alanine aminotransferase and (ALT) viral 
serology tests: Blood samples were collected from the 
antecubital vein. Subjects had blood drawn at the same 
time in the morning on each occasion (between 8 and 10 
AM). Subjects lay supine for 10 min prior to the blood 
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collection. 10 ml of  blood was drawn into a tube con-
taining few milliliters of  sodium citrate; plasma was sepa-
rated from the blood by centrifugation (120× g for 15 
min)at room temperature. Serum alanine aminotransfer-
asewas measured by the colorimetric enzymatic method 
using an automatic spectrophotometer (Bioclin, Quibasa, 
Belo Horizonte, MG, Brazil). All samples were assayed 
in duplicate, and the mean of  the paired results was de-
termined. In addition, serum samples were tested for the 
presence of  HBsAg, HBeAg, and anti-HBeAg antibody 
using radioimmunoassay (Abbott Laboratories, North 
Chicago, IL), while a CobasAmplicor HBV monitor de-
termined the HBV DNA.
 
D. Body mass index (BMI): Weight and height scale 
(Metrotype –England) was used to measure weight and 
height to calculate the body mass index (BMI). Body mass 
index was calculated by dividing the weight in kilograms 
by the square of  the height in meters (Kg/m2). Accord-
ing to the WHO classification, a BMI of  <18.5 kg/m2 is 
under weight, 18.5-24.9 kg/m2 is normal 25-29.9 kg/m2 
is overweight. A BMI of  > 30 kg/m2 is classified as obese 
and this group was further divided into moderate obesity 
(30-34.9 kg/m2), severe obesity (35-39.9 kg/m2) and very 
severe obesity (≤40 kg /m2)13.
 
Procedures
Following the previous evaluation, all patients were di-
vided randomly into the following groups:
1. The training group (Group A): Were submitted 
to the aerobic exercise training to complete a 12-weeks 
treadmill aerobic exercise (Enraf  Nonium, Model display 
panel Standard, NR 1475.801, Holland) which was con-
ducted according to recommendation of  aerobic exercise 
application approved by the American College of  Sports 
Medicine14. Training program included 5 minutes for 
warming–up in the form of  range motion and stretch-
ing exercises, 30 minutes of  aerobic exercise training with 
intensity equal 60-70% of  the individual maximum heart 
rate followed by cooling down for 10 minutes (on tread-
mill with low speed and without inclination). Participants 
had 3 sessions /week for 3 months with close supervision 
of  physical therapist. In addition, a dietician performed 
an interview-based food survey for all participants of  
group (A) for detection of  feeding habits, abnormal di-
etary behavior and to prescribe the balanced low caloric 
diet15, that provided 1200 kilocalories/day for 12 weeks. 
The same dietician continuously monitored all participant 
caloric intakes through reviewing the detailed record of  
food intake every 2 weeks16,17.    
 
Statistical analysis
The mean values of  the investigated parameters obtained 
before and after three months in both groups compared, 
using paired "t" test. Independent "t" test was used for 
the comparison between the two groups (P<0.05).
 
Results
The two groups were considered homogeneous regard-
ing the demographic variables (Table 1). The mean age 
for group, (A) was 38.13± 5.81 years, and the mean age 
of  the group (B) was 36.84 ± 6.16 years. There was no 
significant differences in body mass index (BMI), fasting 
glucose, triglyceride, total cholesterol, high-density lipo-
protein-cholesterol (HDL), systolic, diastolic blood pres-
sure and HBV viral load between both groups.
 
Table 1: Comparison of clinical data between HBV patients in both groups. 
 
  Group (A) Group (B) 
Age (year) 38.13± 5.81 36.84 ± 6.16 
BMI (kg/m2) 31.65 ± 4.12 30.41 ± 5.25 
Fasting glucose (mg/dL) 100.43 ± 10.28 97.92 ± 9.67 
Triglyceride (mg/dL) 131.31 ± 13.70 128.11 ± 11.54 
Total cholesterol (mg/dL) 193.27 ± 18.06 191.76 ± 16.18 
HDL-C (mg/dL) 48.75 ± 8.92 50.13 ± 9.16 
Systolic blood pressure (mm Hg) 118.14 ± 15.13 115.88 ± 16.10 
Diastolic blood pressure (mm Hg) 76.93 ± 6.38 75.11 ± 5.76 
HBV DNA (IU/mL) 3.57 ± 0.85 × 106 3.32 ± 0.78 × 106 
 
BMI: Body Mass Index; HDL-C: High-density lipoprotein-cholesterol. 
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There was a 24.7%, 36.8%, 30.8%, 40.7%, 28.6%, 25.9%, 
33.3% and 14.3 % reduction in mean values of  alanine 
aminotransferase (ALT), white blood cells, total neutro-
phil count, monocytes, CD3, CD4 ,CD8 and BMI respec-
tively in group (A) at the end of  the study. The mean val-
ues of  alanine aminotransferase (ALT), white blood cells, 
total neutrophil count, monocytes, CD3, CD4 ,CD8 and 
BMI were significantly decreased in group received aero-
bic exercise training in addition to diet regimen (Table 
2), While the results of  group (B) received no treatment 
intervention were not significant (Table 3). 
Table 2: Mean value and significance of body mass index, : alanine aminotransferase, white blood 





T-value Significance Before the 
study 
At the end 
of the study 
BMI (kg/m2) 31.65 ± 4.12* 27.13 ± 3.74 8.16 P<0.05 
ALT activity(IU/L) 74.23 ± 5.68* 55.87 ± 4.54 6.81 P<0.05 
White blood cells 
count  (109/µL) 8.94 ± 2.97* 5.65 ± 2.53 8.12 P<0.05 
Total neutrophil count 
(109/µL) 6.23 ± 1.86* 4.31 ± 1.54 7.53 P<0.05 
Monocytes (109/µL) 0.54 ± 0.14* 0.32 ± 0.12 5.74 P<0.05 
CD3 count (109/L) 1.71 ± 0.82* 1.22 ± 0.61 6.43 P<0.05 
CD4 count (109/L) 1.43 ± 0.61* 1.06 ± 0.52 6.18 P<0.05 
CD8 count (109/L) 0.78 ± 0.17* 0.52 ± 0.11 5.36 P<0.05 
 
BMI= Body Mass Index; ALT: alanine aminotransferase; (*) indicates a significant difference  
between the two groups, P < 0.05. 
Table 3: Mean value and significance of body mass index, : alanine aminotransferase, white blood 





T-value Significance Before the 
study 
At the end 
of the study 
BMI (kg/m2) 30.41 ± 5.25 30.93 ± 5.27 0.732 P>0.05 
ALT activity(IU/L) 73.81 ± 4.82 76.26 ± 4.91 0.815 P>0.05 
White blood cells 
count  (109/µL) 8.86 ± 2.67 9.15 ± 2.74 0.693 
P>0.05 
Total neutrophil count 
(109/µL) 5.91 ±1.73 6.16 ±1.81 0.712 
P>0.05 
Monocytes (109/µL) 0.51 ± 0.12 0.54 ± 0.16 0.461 P>0.05 
CD3 count (109/L) 1.63 ± 0.71 1.70 ± 0.78 0.355 P>0.05 
CD4 count (109/L) 1.38 ± 0.57 1.43 ± 0.52 0.298 P>0.05 
CD8 count (109/L) 0.69 ± 0.13 0.73 ± 0.18 0.267 P>0.05 
 
BMI= Body Mass Index;    (*) indicates a significant difference between the two groups, P < 0.05. 
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In addition, there were significant differences between mean levels of  the investigated parameters in groups at 
the end of  the study (Table 4).  (P<0.05).
  
Table 4: Mean value and significance of body mass index, : alanine aminotransferase, white blood 
cells, total neutrophil, monocytes, CD3, CD4 and CD8 count of group (A) and group (B) at the end 
of the study. 
  
  Mean +SD T-value Significance Group (A) Group (B) 
BMI (kg/m2) 27.13 ± 3.74 30.93 ± 5.27 7.12 P<0.05 
ALT activity(IU/L) 55.87 ± 4.54 76.26 ± 4.91 6.10 P<0.05 
White blood cells 
count  (109/µL) 5.65 ± 2.53 9.15 ± 2.74 7.21 
P<0.05 
Total neutrophil count 
(109/µL) 4.31 ± 1.54 6.16 ±1.81 6.42 
P<0.05 
Monocytes (109/µL) 0.32 ± 0.12 0.54 ± 0.16 4.31 P<0.05 
CD3 count (109/L) 1.22 ± 0.61 1.70 ± 0.78 5.82 P<0.05 
CD4 count (109/L) 1.06 ± 0.52 1.43 ± 0.52 5.23 P<0.05 
CD8 count (109/L) 0.52 ± 0.11 0.73 ± 0.18 4.76 P<0.05 
 
BMI= Body Mass Index;   ALT: Alanine Aminotransferase; (*) indicates a significant difference between the two 
groups, P < 0.05. 
  
Discussion
The impact of  obesity on the immune system is well 
known and serum alanine aminotransferase (ALT) is 
elevated among obese HBV patients18. ALT activity is a 
commonly used surrogate marker for the evaluation of  
hepatocellular damage19. Several epidemiologic studies 
have reported that obesity is an important risk factor for 
elevated ALT activity in individuals with no apparent un-
derlying cause of  liver disease20-22. A comparable relation 
between ALT activity and BMI has been observed in a 
healthy blood donor population23,24. It has been reported 
that high-normal ALT activity predicts insidious, contin-
ued liver damage in patients with chronic hepatitis B and 
it has been speculated that obesity may carry with it a 
continuum of  risk of  subtle hepatic injury even in in-
dividuals with mild ALT elevation25,26. Participants were 
co-operative and strictly followed the directions of  the 
research team. The main finding of  the present study was 
that, weight-reducing program was associated with sig-
nificant modulation of  ALT, white blood cells, total neu-
trophil count, monocytes, CD3, CD4 and CD8 in obese 
patients with HBV as a result of  weight loss, these results 
are in line with many previous studies.
 
Wasinski and colleagues conducted a study on mice who 
were submitted to chronic swimming training or a 30% ca-
loric restriction after consuming a high-fat diet. The mice 
were subjected to swimming sessions 5 times per week 
for 6 weeks. Data demonstrated that exercise and caloric 
restriction modulate resident immune cells in adipose 
tissues27. Carpenter and colleagues evaluated the forced 
and voluntary exercise as weight-loss treatments in diet-
induced obese (DIO) mice and assessed the effects of  
weight loss on monocyte concentration and cell-surface 
expression of  Toll-like receptor. Results confirmed that 
short-term exercise and low-fat diet consumption over 
the 8 weeks caused significant weight loss and altered im-
mune profiles28.  While, Viardot and colleagues looked at 
13 obese people with Type 2 diabetes or pre-diabetes who 
were limited to a diet of  between 1000 and 1600 calories 
a day for 24 weeks. Gastric banding was performed at 12 
weeks to help restrict food intake further. Their results 
showed an 80% reduction of  pro-inflammatory T-helper 
cells, as well as reduced activation of  other circulating im-
mune cells (T cells, monocytes and neutrophils) and de-
creased activation of  macrophages in fat29.
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The possible mechanism of  immune system modulation 
by weight reduction could be explained by reduction of  
adipose tissues which is not only a storage organ, but pro-
duces close to 100 cytokines. These secreted adipokines 
are directly correlated to the increased adipose tissue mass 
and play an intricate role in various aspects of  the innate 
and adaptive immune response and participate in a wide 
variety of  physiological or physiopathological processes 
including food intake, insulin sensitivity and inflamma-
tion30. In addition, weight reduction reduces serum level 
of  leptin. Leptin has pleiotropic effects on immune cell 
activity as evidenced from the presence of  leptin recep-
tors on all immune cells of  both the arms of  innate and 
adaptive immunity31. However, it should be conceded 
that the preponderance of  men in the sample limits the 
generalisation of  the findings as males are more likely 
to remain persistently infected with HBV than women. 
Finally, obese patients with HBV are recommended to 
reduce their body weight to improve their liver function 
and immune system parameters.
 
Conclusion
Based on our findings, weight loss modulates serum ala-
nine aminotransferase and immune system parameters of  
patients with hepatitis B virus infection.
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